Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesFluid washings, Hybridization and Sex Chromatin Identification ProceduresCPT cpt-88121-urinary-tract-in-situ-hybridization-morphometry
    Ask Trek AI about this page

    CPT 88121: Urine In Situ Hybridization with 3–5 Probes

    Medicare pays $275 on average nationally for this procedure.

    CPT code 88121 describes a technical laboratory test performed on a urinary tract specimen using in situ hybridization with three to five molecular probes for computer-assisted morphometric analysis, assessing the number and form of cellular structures; service type: technical molecular cytogenetic analysis; typical site of service: clinical laboratory or pathology laboratory processing urinary specimens.

    For related coverage guidance, see recent payer policy updates: Automated Ambulatory Blood Pressure Monitoring for Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure, Cardiology - Ivabradine, Cardiac Computed Tomography (CCT)/Coronary Computed Tomographic Angiography (CCTA).

    Customize your policy alerts

    Sign up for cpt 88121 policy alerts

    Get alerted when payer policies referencing 88121 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A 62-year-old patient with a history of recurrent gross hematuria and a prior urine cytology showing atypical urothelial cells presents for further evaluation. The urologist orders an in situ hybridization (ISH) assay with three to five molecular probes on a urinary tract specimen to detect chromosomal abnormalities and assess cellular morphology quantitatively using computer-assisted morphometric analysis. A clinical laboratory receives the voided urine specimen or a bladder wash, performs specimen processing and slide preparation, applies fluorescent or chromogenic probes targeting specific chromosomal loci, and runs image capture with computer-assisted morphometry to enumerate signal patterns and abnormal nuclear forms. Results are reported to the ordering provider and used alongside cystoscopy, imaging, and cytology to guide surveillance or diagnostic decisions for urothelial carcinoma or high-grade dysplasia. Typical sites of service include hospital-based or independent clinical laboratories and outpatient pathology laboratories that receive specimens from urology clinics or ambulatory surgical centers.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    88112Cytopathology, smears or monolayer preparations; without interpretation by a physicianPerformed on urine specimens as initial cytologic preparation prior to or alongside ISH testing.
    88113Cytopathology, smears or monolayer preparations; with interpretation by a physicianPhysician-interpreted urine cytology commonly accompanies ISH to correlate morphologic findings.
    88342Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stainMay be performed on cell block or cytology specimens to evaluate protein markers complementary to ISH results.
    88377Computer-assisted morphometric analysis, each specimen; interpretation and reportDescribes the image analysis component that quantifies nuclear and cellular features used with ISH signal enumeration.
    88367Morphometric analysis, tumor or other specimen quantification, manual or computer-assistedAdditional morphometric quantification codes that may be used when multiple analytic techniques are applied to the specimen.

    Related Modifiers

    8 rows

    ModifierDescriptionWhen to Use
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    90Modifier ‑90 (Reference/Outside Laboratory) indicates that a laboratory test was performed by an entity other than the treating or reporting provider. The American Medical Association defines…- Use CPT modifier -90 when a laboratory test is performed by an outside/reference laboratory (an entity other than the treating or reporting physician or qualified professional) and the claim needs…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    62Modifier 62 indicates that two surgeons function as co‑surgeons, each performing distinct parts of the same primary surgical procedure. It is appended to the primary procedure code (and any…- Use modifier -62 when two surgeons act as co‑surgeons (both primary surgeons) on a single definitive primary procedure, each performing distinct parts of the same surgical procedure (append -62 to…
    82Modifier 82 is appended to a surgical CPT code to indicate that an attending physician acted as an assistant because a qualified resident surgeon was unavailable. In teaching hospitals it documents…- When to use: Append modifier 82 in teaching-hospital settings to indicate a physician served as an assistant surgeon because a qualified resident surgeon was unavailable (includes situations where…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    91Modifier 91 — “Repeat Clinical Diagnostic Laboratory Test” — is appended when the exact same CPT laboratory test is performed more than once for the same patient on the same day because serial,…- Use modifier 91 when the exact same CPT laboratory test is performed more than once on the same patient on the same date because serial or repeated testing is medically necessary to monitor…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207Q00000X
    208C00000X
    3336C0002X
    207XX0004X
    174200000X
    320900000X
    111NP0017X
    156FC0800X

    Related ICD-10-CM Codes

    29 rows

    ICD-10-CM CodeDescription
    C67.9Malignant neoplasm of bladder, unspecified
    D09.0Carcinoma in situ of bladder
    D41.4Neoplasm of uncertain behavior of bladder
    N10Acute pyelonephritis
    N12Tubulo-interstitial nephritis, not specified as acute or chronic
    N13.30Unspecified hydronephrosis
    N13.6Pyonephrosis
    N20.0Calculus of kidney
    N20.1Calculus of ureter
    N20.2Calculus of kidney with calculus of ureter

    Showing 1–10 of 29

    Related Payer Policy Updates

    Specialty: Cardiology1 / 3

    10 rows

    PolicyPayerEffective Date
    Automated Ambulatory Blood Pressure Monitoring for Diagnosis of Hypertension in Patients with Elevated Office Blood PressureBluecross Idaho2026-11-01
    Cardiology - IvabradineCigna2026-10-15
    Cardiac Computed Tomography (CCT)/Coronary Computed Tomographic Angiography (CCTA)univerahealthcare2026-10-15
    Percutaneous Ventricular Assist DeviceUnitedHealthcare2026-10-01
    Cardiovascular Disease Risk AssessmentOscar Health2026-10-01
    Biomarkers for Myocardial Infarction and Chronic Heart FailureOscar Health2026-10-01
    Multiple Procedure Payment Reduction for Diagnostic Cardiovascular ProceduresBlue Cross Blue Shield - Maine2026-10-01
    Left Atrial Appendage Closure Devicesexcellus_health_plan_inc2026-09-17
    Left Atrial Appendage Closure Devicesuniverahealthcare2026-09-17
    Cardiac Omnibus CodesCigna2026-09-15

    Related Codes

    CPT-88104-CYTOPATHOLOGY-SMEAR-PREP-AND-INTERPRETATION

    CPT 88104: Cytopathology Smear Preparation and Interpretation

    CPT-88106-NON-GYNECOLOGIC-CYTOPATHOLOGY-SMEAR-SIMPLE-FILTER

    CPT 88106: Cytopathology Smear of Non-Cervical Fluids

    CPT-88108-CYTOPATHOLOGY-FLUID-SMEAR-CONCENTRATION-TECHNIQUE

    CPT 88108: Cytopathology Concentration Smear Preparation and Interpretation

    CPT-88112-LIQUID-BASED-CYTOPATHOLOGY-SELECTIVE-CELLULAR-ENHANCEMENT

    CPT 88112: Selective Cellular Enhancement for Cytopathology

    CPT-88120-URINARY-TRACT-IN-SITU-HYBRIDIZATION-MORPHOMETRIC-ANALYSIS

    CPT 88120: In Situ Hybridization on Urinary Tract Specimen, 3–5 Probes

    CPT-88125-FORENSIC-CYTOPATHOLOGY-TECHNICAL-SERVICE

    CPT 88125: Cytopathology Specimen Analysis for Forensic Testing

    CPT-88130-SEX-CHROMATIN-BARR-BODY-ANALYSIS

    CPT 88130: Sex Chromatin (Barr Body) Analysis

    CPT-88140-PERIPHERAL-BLOOD-SMEAR-SEX-CHROMATIN-IDENTIFICATION

    CPT 88140: Peripheral Blood Smear for Sex Chromatin Identification

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.